Rathbones Group PLC Pep Gen Inc. Transaction History
Rathbones Group PLC
- $22 Billion
- Q2 2025
A detailed history of Rathbones Group PLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 32,003 shares of PEPG stock, worth $152,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,003
Previous 32,003
-0.0%
Holding current value
$152,334
Previous $45,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PEPG
# of Institutions
52Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$50.9 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$13.1 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$7.18 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$7.06 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$6.43 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $112M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...